Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to 202 ...

Scientists in Turkey found that the Pfizer COVID-19 vaccine impacted some people's corneas, according to a study.

Researchers looked at how the vaccine affected patients' corneas - the clear front part of the eye that allows light to come ...

Pfizer-BioNTech's COVID-19 vaccine appears to be safe and effective for children ages 6 months to 5 years, ... No new safety concerns were identified during the trial, ...

A new study suggests a potential link between the Pfizer COVID-19 vaccine and serious eye conditions like retinal vascular ...

Pfizer CEO Dr. Albert Bourla joined “GMA3: What You Need To Know” Monday to discuss the drug-maker's coronavirus vaccine after early analysis shows it to be 90% effective at preventing COVID-19.

In a promising development, an initial glimpse at the data from Pfizer's ongoing late-stage clinical trial shows that the company's vaccine is more effective at preventing COVID-19 than placebo.

A vaccine safety monitoring system in late November picked up a signal that the updated Pfizer coronavirus vaccine booster was possibly linked to an increased risk of strokes in people 65 and older.

Pfizer has accumulated enough safety data on its Covid-19 vaccine and is preparing to file for emergency use authorization from the US Food and Drug Administration, company CEO Albert Bourla said ...

Pfizer is the first drug company to release data from a large Phase 3 trial for a coronavirus vaccine designed to show both effectiveness and safety. Hotspots ranked Start the day smarter ☀️ ...

London — U.S. drugmaker Pfizer said Monday that human trials suggest its coronavirus vaccine is 90% effective at preventing COVID-19 infections in people not known to have had the virus already.

Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has ...